Literature DB >> 16898343

Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review.

Won Chan Lee1, Sanjeev Balu, David Cobden, Ashish V Joshi, Chris L Pashos.   

Abstract

A systematic literature review was conducted using a comprehensive list of relevant search terms (1990-2005) to identify studies on adherence among patients with diabetes, and its economic effect. A lack of adequate treatment adherence (36%-87%) among patients with diabetes was confirmed, primarily measured by medication possession ratio (MPR). Adherence varied among oral agent-only (36%-87%) versus concomitant or insulin-only (54%-81%) regimens. Economic consequences of adherence were a decrease in health care costs, ranging from 8.6% to 28.9%, with an approximate 10% increase in MPR, mostly in the form of a 4.1% to 31.0% decrease in hospitalization. Increased cost sharing was associated with a 9% to 23% decline in medication use.

Entities:  

Mesh:

Year:  2006        PMID: 16898343

Source DB:  PubMed          Journal:  Manag Care Interface        ISSN: 1096-5645


  41 in total

1.  The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support.

Authors:  Chandra Y Osborn; Leonard E Egede
Journal:  Gen Hosp Psychiatry       Date:  2012-03-07       Impact factor: 3.238

2.  Adherence to treatment guidelines and therapeutic regimens: a US claims-based benchmark of a commercial population.

Authors:  C Ron Cantrell; Julie L Priest; Christopher L Cook; Jack Fincham; Steven P Burch
Journal:  Popul Health Manag       Date:  2010-12-13       Impact factor: 2.459

3.  Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.

Authors:  Glenn Matfin; Kate Van Brunt; Alan G Zimmermann; Rebecca Threlkeld; Debra A Ignaut
Journal:  J Diabetes Sci Technol       Date:  2015-04-21

4.  Quality of care associated with common chronic diseases in a 9-state Medicaid population utilizing claims data: an evaluation of medication and health care use and costs.

Authors:  Julie L Priest; C Ron Cantrell; Jack Fincham; Christopher L Cook; Steven P Burch
Journal:  Popul Health Manag       Date:  2010-12-13       Impact factor: 2.459

5.  Is there an impatience genotype leading to non-adherence to long-term therapies?

Authors:  G Reach
Journal:  Diabetologia       Date:  2010-04-21       Impact factor: 10.122

6.  Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.

Authors:  Francesco Patti
Journal:  Patient Prefer Adherence       Date:  2010-02-04       Impact factor: 2.711

7.  Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach.

Authors:  David S Cobden; Louis W Niessen; Frans Fh Rutten; W Ken Redekop
Journal:  Patient Prefer Adherence       Date:  2010-09-07       Impact factor: 2.711

8.  Impact of human factors on clinical protocol performance: a proposed assessment framework and case examples.

Authors:  J Geoffrey Chase; Steen Andreassen; Karsten Jensen; Geoffrey M Shaw
Journal:  J Diabetes Sci Technol       Date:  2008-05

9.  Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System.

Authors:  Darlene M Dreon; Trevor M Hannon; Brett Cross; Brett J Carter; Nicholas S Mercer; Jason H Nguyen; Andy Tran; Peter A Melendez; Nancy Morales; Jonathan E Nelson; Meng H Tan
Journal:  J Diabetes Sci Technol       Date:  2018-02-28

10.  A novel method for measuring patients' adherence to insulin dosing guidelines: introducing indicators of adherence.

Authors:  Massoud Toussi; Carine Choleau; Gérard Reach; Michel Cahané; Avner Bar-Hen; Alain Venot
Journal:  BMC Med Inform Decis Mak       Date:  2008-12-05       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.